Robert Kratzke

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.

|Apr 28, 2026
Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.

|Feb 13, 2026
Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Oct 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.

Timothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack

|Aug 29, 2024
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers.

Libang Yang, Adam Gilbertsen, Blake Jacobson

|Aug 12, 2023
SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer.

Libang Yang, Adam Gilbertsen, Blake Jacobson

Pageof 2

Frequent Collaborators

1 joint publications

Amit A Kulkarni

1 joint publications

Naomi Fujioka

1 joint publications

Pankaj Gupta

1 joint publications

Niveditha Subbiah